Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Ltd.
Your view on VFY.AX
Overview
What the company does, where it operates, and who runs it.
About Vitrafy Life Sciences Ltd.
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Brenton Michael Leslie Owens
- Headquarters
- Suite 2, Level 11, 385 Bourke Street, Melbourne, VIC, AU
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Brenton Michael Leslie Owens
- Headquarters
- Suite 2, Level 11, 385 Bourke Street, Melbourne, VIC, AU
Vitrafy Life Sciences Limited has developed cryopreservation technology that dramatically improves cell survival rates across multiple applications including blood platelets, cell & gene therapies, aquaculture and bovine reproduction.
The Company provides complete cryopreservation solutions through its managed service revenue model, utilising its FDA-registered Smart Freezing and Smart Thawing devices, integrated LifeChain software platform, and Smart Packaging systems.
Vitrafy has designed and developed an innovative cryopreservation solution, which includes smart cryopreservation medical devices and packaging, and a sample quality management software platform known as LifeChain.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Vitrafy Life Sciences Ltd.. Starting points for Vitrafy Life Sciences Ltd.: EPS -AUD 0.22, beta 1.93 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Vitrafy Life Sciences Ltd.. Vitrafy Life Sciences Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Vitrafy Life Sciences Ltd.. Trailing twelve-month EPS for Vitrafy Life Sciences Ltd. stands at -AUD 0.22. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Vitrafy Life Sciences Ltd.. Vitrafy Life Sciences Ltd. has reported as a listed company since 2024. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| PMSNFProteome Sciences plc | Healthcare | OTC | $11.8M | ||
| QDELQuidelOrtho Corporation | Healthcare | NASDAQ | $570.9M | ||
| SDCCQSmileDirectClub, Inc. | Healthcare | OTC | $13,395 | ||
| SIShoulder Innovations, Inc. | Healthcare | NYSE | $421.6M | ||
| SSMXFSysmex Corporation | Healthcare | OTC | $5.4B | ||
| SSMXYSysmex Corporation | Healthcare | OTC | $5.5B | ||
| STESTERIS plc | Healthcare | NYSE | $24.8B | ||
| TRIBTrinity Biotech plc | Healthcare | NASDAQ | $126.4M | ||
| UAHCUnited American Healthcare Corporation | Healthcare | OTC | $1.1M | ||
| UEECUnited Health Products, Inc. | Healthcare | OTC | $14.9M | ||
| VMTHFVenus Medtech (Hangzhou) Inc. | Healthcare | OTC | $184.7M | ||
| VVVVvVARDIS HOLDING AG Class A | Healthcare | NYSE | $558.7M | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Vitrafy Life Sciences Ltd.. Coverage tracks Vitrafy Life Sciences Ltd. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Vitrafy Life Sciences Ltd.